Nakagawa A, Mitsuda D, Sado M et al: Effectiveness of Supplementary Cognitive-Behavioral Therapy for Pharmacotherapy-Resistant Depression: A Randomized Controlled Trial. J Clin Psychiatry. 2017; 78 (8) : 1126-35.
Sado M, Koreki A, Ninomiya A et al: Cost-effectiveness analyses of augmented cognitive behavioral therapy for pharmacotherapy-resistant depression at secondary mental health care settings. Psychiatry Clin Neurosci. 2021; 75 (11) : 341-50.
Hayashi Y, Yoshinaga N, Sasaki Y et al: How was cognitive behavioural therapy for mood disorder implemented in Japan? A retrospective observational study using the nationwide claims database from FY2010 to FY2015. BMJ open. 2020; 10 (5) : e033365.
Kazdin AE: Addressing the treatment gap: A key challenge for extending evidence-based psychosocial interventions. Behav Res Ther. 2017; 88: 7-18.
Bouchard S, Paquin B, Payeur R et al: Delivering cognitive-behavior therapy for panic disorder with agoraphobia in videoconference. Telemed J E Health. 2004; 10 (1) : 13-25.